https://doi.org/10.1038/sj.bjc.6605776
A
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
114
Papers
5.5K
Citations
31
h-index
52
i10-index
Albert Abad is an academic researcher from Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Cancer Treatment and Pharmacology & Genetic factors in colorectal cancer. The author has an h-index of 31, co-authored 97 publications.
ORCID: 0000-0002-0101-3714Papers by this author
worksUGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy
2010 · British Journal of Cancer · 88 citations
First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled Analysis
2021 · Drugs & Aging · 7 citations
https://doi.org/10.1007/s40266-021-00834-w
Liquid biopsy, big data and artificial intelligence as a new global clinical trial model in targeted therapy
2023 · The Journal of Liquid Biopsy · 3 citations
https://doi.org/10.1016/j.jlb.2023.100008
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat